Arsenic trioxide: Its role in acute promyelocytic leukemia and potential in other hematologic malignancies

Keyphrases

• Hematological Malignancies 100%
• Acute Promyelocytic Leukemia 100%
• Arsenic Trioxide 100%
• Clinical Investigator 50%
• Relapse Rate 50%
• Preclinical Data 50%
• Combination Therapy 50%
• Clinical Benefit 50%
• In Vitro Data 50%
• Reducing Agent 50%
• Treatment Choice 50%
• STI571 50%
• Antineoplastic Agents 50%
• Glutathione 50%
• Anthracycline-based Chemotherapy 50%
• Relapsed Patients 50%
• Rare Subtype 50%
• Multiple Mechanisms of Action 50%

Medicine and Dentistry

• Acute Promyelocytic Leukemia 100%
• In Vitro 100%
• Hematologic Malignancy 100%
• Arsenic Trioxide 100%
• Combination Therapy 50%
• Anthracycline 50%
• Recurrence Risk 50%
• Glutathione 50%
• Reducing Agent 50%
• Resuscitation 50%
• Diseases 50%
• Sexually Transmitted Infection 50%
• Antineoplastic Agent 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Arsenous Acid 100%
• Arsenite 100%
• Hematologic Malignancy 100%
• Promyelocytic Leukemia 100%
• Chemotherapy 50%
• Recurrence Risk 50%
• Glutathione 50%
• Reducing Agent 50%
• Combination Therapy 50%
• Anthracycline 50%
• Diseases 50%
• Antineoplastic Agent 50%